Services

High Intensity Focused Ultrasound

Miami urologist Dr. David Robbins is proud to offer patients the very latest state-of-the-art therapy for prostate cancer.

Diagram of high intensity focused ultrasound: a transducer directs ultrasound energy to a focal point within the prostate, concentrating the energy at the target while sparing tissue along the path.
HIFU concentrates ultrasound energy at a focal point inside the prostate.

What is HIFU?

HIFU stands for high-intensity focused ultrasound, which is a minimally invasive technique for treating diseased tissue with precise, focused ultrasound waves that raise the temperature of the target to nearly 90 degrees Celsius (190 degrees Fahrenheit) in two to three seconds. This rapid-firing heat effectively destroys the targeted tissue but leaves the surrounding healthy tissue intact.

What is HIFU with the Sonablate® 500?

The Sonablate 500 is a minimally invasive medical device, developed by Focus Surgery, Inc., that uses HIFU to treat localized prostate cancer and benign prostatic hyperplasia (BPH). The Sonablate 500 uses a single transducer to obtain real-time images of the prostate during treatment and provides treatment in one to four treatment zones depending on the size of the prostate. The Sonablate 500 software allows the surgeon to safely ablate the entire gland in one to three hours with a single treatment.

The high intensity focused ultrasound console and treatment cart.

How exactly does Sonablate HIFU treat prostate disease?

The Sonablate directs intersecting, precision-focused ultrasound waves at the diseased tissue only and leaves healthy cells surrounding the prostate untouched. HIFU uses non-ionizing, or clean, energy so the procedure may be repeated if necessary without damaging other tissue, unlike radiation-based therapies.

What are the results of the Sonablate HIFU treatment?

Published series report encouraging results in carefully selected men — for example, work from Toyaki Uchida’s group in Japan reporting that most low-risk patients remained disease-free at four years, and work from Mark Emberton’s group in England reporting low PSA levels three months after treatment. Those are single series in specific patient groups rather than head-to-head comparisons against surgery or radiation, and the figures depend heavily on who was selected for treatment. We will go through what the evidence does and does not show for your situation.

What are the recovery times and side effects of Sonablate HIFU for prostate cancer?

Patients can typically return to their normal lifestyle within a few days after the 1-4hour procedure. Recovery involves wearing a catheter for 2-3 weeks. Some HIFU patients experience urination frequency or urgency or mild discomfort or discharge in the urinary stream. Studies performed outside the U.S. report that potential side effects may also include urinary stricture (18%)2, retention (0.6%)1, incontinence (0.6%)1, erectile dysfunction (20%)1 and rectal fistula (1%)1.

Does HIFU treat only cancer cells? How?

Sonablate HIFU treats the entire prostate by targeting tissue in the overlapping treatment zones. The tissue is heated rapidly in targets known as lesions until the entire prostate is ablated.

What is the history of HIFU and how long has it been used?

Research on HIFU began in the 1950s at Indiana University (IU) in Indianapolis, IN. In 1994, Dr. Michael Marberger and Dr. Stephan Madersbacher performed the first human prostate cancer study at the University of Vienna in Austria using the Sonablate 200. They treated 29 human prostates in the body before performing a radical prostatectomy in order to see if the energy delivered was enough to destroy the targeted tissue. The study found that treatment could be performed safely and be repeated if necessary.

Other significant dates and milestones include:

  • 1995—a study done at IU showed that the whole prostate could be treated without damaging the prostate capsule or rectal wall.
  • 1999—Dr. Toyaki Uchida began treating patients using the Sonablate® 200, the first generation of the Sonablate device.
  • 2001—The Sonablate 500 received its CE mark (approval for the use) in Europe.
  • 2004—US HIFU was founded and began placing Sonablate devices in different areas where HIFU was approved. It has put devices in Canada, Mexico, Costa Rica, the Caribbean, India, and Argentina
  • 2005—Health Canada approved the Sonablate 500.
  • 2006—The first Sonablate HIFU procedures were performed in Toronto, Canada.
  • 2008—Sonablate HIFU was first performed in India.

Where is Sonablate HIFU available now?

Sonablate has been authorized for marketing in the United States since October 2015, and a further clearance followed in 2016. It is also in use across Europe, Canada, parts of Asia, South America, India and the Caribbean.

The scope of that authorization is worth stating precisely, because it is often reported loosely: Sonablate is FDA-cleared for the ablation of prostate tissue. That is not the same as being approved for the treatment of prostate cancer, and no HIFU system holds such an approval. Whether HIFU is a sensible choice for your cancer is a clinical decision made with your urologist, weighing your stage, grade and PSA against the alternatives — not something the device’s regulatory status decides for you.

Contact Us

We’re here to help. Schedule your visit or ask a question today.

No question is too small — and nothing you share here surprises us. Reach out however feels easiest.

  • Call(305) 672-4222
  • Visit12411 Biscayne Boulevard
    North Miami, FL 33181
  • HoursMonday–Friday, 9:00 am – 5:00 pm

Your message goes to Dr. Robbins’ own team — you’ll hear back within one business day.

Get More Information

By sending this form you agree to our Terms of Service, Privacy Policy, and Notice of Privacy Practices.

Your message is confidential. We’ll respond within one business day.

We’re Here When You Need Us

Our Office

Visit us in North Miami, or call to book your appointment.

North Miami

  • Address12411 Biscayne Boulevard
    North Miami, FL 33181
  • Phone(305) 672-4222
  • Fax(305) 944-3624
Office hours
Monday – Friday9:00 am – 5:00 pm
Saturday – SundayClosed

Associations

Proud Members Of

American Board of Urology American College of Surgeons NYU Medical Center Miller School of Medicine Brandeis University Greenlight